Age
Item
aged 30 to 70 at the baseline visit;
boolean
C0001779 (UMLS CUI [1])
Body Weight
Item
weight is less than or equal to 350 lbs;
boolean
C0005910 (UMLS CUI [1])
Pregnancy Absent | Breast Feeding Absent
Item
not currently pregnant or breastfeeding;
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Breast implants Absent
Item
no breast implants currently;
boolean
C0179412 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Absence Skin infection Breast | Absence Skin wound Breast
Item
no active skin infections or wounds overlying the breast;
boolean
C0332197 (UMLS CUI [1,1])
C0037278 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C0332197 (UMLS CUI [2,1])
C0564444 (UMLS CUI [2,2])
C0006141 (UMLS CUI [2,3])
Breast Diameter | Appropriateness Ultrasound Tomography
Item
the breast, as visually assessed, can fit through the ultrasound tomography ring (i.e., 20 cm in diameter);
boolean
C0006141 (UMLS CUI [1,1])
C1301886 (UMLS CUI [1,2])
C0814634 (UMLS CUI [2,1])
C3897255 (UMLS CUI [2,2])
Exclusion Criteria | Illness Serious Preventing Informed Consent | Mental disorder Serious Preventing Informed Consent
Item
no serious medical or psychiatric illnesses that would prevent voluntary informed consent.
boolean
C0680251 (UMLS CUI [1])
C0221423 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C1292733 (UMLS CUI [2,3])
C0021430 (UMLS CUI [2,4])
C0004936 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C1292733 (UMLS CUI [3,3])
C0021430 (UMLS CUI [3,4])
Clinical Study Case
Item
cases:
boolean
C1706256 (UMLS CUI [1])
Tamoxifen Planned
Item
is planning to take tamoxifen for clinical indications including:
boolean
C0039286 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Patient referral Risk Breast Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Risk Breast Carcinoma Gail Model
Item
1. a referral from a health care professional based on a woman s personal risk of breast cancer (i.e., brca1/2 mutation carrier or 5-year predicted risk of breast cancer of greater than or equal to 1.66% according to the gail model [30]; or
boolean
C0034927 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C3899965 (UMLS CUI [2])
C3899964 (UMLS CUI [3])
C0035647 (UMLS CUI [4,1])
C0678222 (UMLS CUI [4,2])
C1511297 (UMLS CUI [4,3])
Invasive carcinoma of breast Estrogen receptor positive | DCIS | Lobular carcinoma in situ of breast | Atypical lobular hyperplasia Affecting Breast | Atypical ductal hyperplasia Affecting Breast
Item
2. a diagnosis with invasive, estrogen receptor positive breast cancer, ductal carcinoma in situ, lobular carcinoma in situ, or atypical lobular or ductal hyperplasia affecting one breast; and
boolean
C0853879 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C0007124 (UMLS CUI [2])
C0279563 (UMLS CUI [3])
C0442835 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0006141 (UMLS CUI [4,3])
C0442834 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C0006141 (UMLS CUI [5,3])
Breast Carcinoma Absent Breast Contralateral
Item
3. has never been diagnosed with breast cancer in the breast contralateral to the current diagnosis;
boolean
C0678222 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C0441988 (UMLS CUI [1,4])
Chemotherapy Absent | Absence Chemotherapy Planned
Item
is not receiving or currently planning to take chemotherapy.
boolean
C0392920 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332197 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
Comparison Group | Screen Negative
Item
screen-negative comparison group:
boolean
C1707455 (UMLS CUI [1,1])
C0441833 (UMLS CUI [1,2])
C0220908 (UMLS CUI [2,1])
C1513916 (UMLS CUI [2,2])
Mammography | Recommendation Screening Continuous | BI-RADS
Item
the most recent mammogram resulted in recommendations for continued routine screening (i.e., birads diagnostic score of 1 or "2");
boolean
C0024671 (UMLS CUI [1])
C0034866 (UMLS CUI [2,1])
C1710032 (UMLS CUI [2,2])
C0549178 (UMLS CUI [2,3])
C1511314 (UMLS CUI [3])
Oral Contraceptives Absent | Menopausal hormone therapy Absent
Item
not currently taking oral contraceptives or menopausal hormone therapy;
boolean
C0009905 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0282402 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Breast Carcinoma Previous Absent | Antineoplastic Agents Absent | Absence Therapeutic radiology procedure Malignant Neoplasms
Item
not been previously diagnosed with breast cancer or received medications or radiation for any type of cancer;
boolean
C0678222 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0003392 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0332197 (UMLS CUI [3,1])
C1522449 (UMLS CUI [3,2])
C0006826 (UMLS CUI [3,3])
Exclusion Criteria | Pharmaceutical Preparations Lowering Breast Carcinoma Risk | Tamoxifen | Raloxifene
Item
not taking medicines (such as tamoxifen or raloxifene) to lower her breast cancer risk.
boolean
C0680251 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C2003888 (UMLS CUI [2,2])
C0678222 (UMLS CUI [2,3])
C0035647 (UMLS CUI [2,4])
C0039286 (UMLS CUI [3])
C0244404 (UMLS CUI [4])